| Breakdown | TTM | Oct 2025 | Apr 2024 | Oct 2023 | Oct 2022 | Oct 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 32.29B | 31.06B | 34.98B | 25.78B | 42.78B | 37.15B |
| Gross Profit | 13.70B | 13.17B | 13.26B | 7.93B | 14.19B | 13.11B |
| EBITDA | 2.90B | 2.19B | 3.86B | -964.00M | 3.77B | 3.96B |
| Net Income | 353.00M | 220.00M | 1.14B | -2.49B | 1.48B | 1.61B |
Balance Sheet | ||||||
| Total Assets | 41.19B | 41.57B | 42.40B | 43.22B | 47.54B | 43.26B |
| Cash, Cash Equivalents and Short-Term Investments | 4.90B | 5.16B | 6.03B | 5.61B | 7.38B | 5.75B |
| Total Debt | 11.02B | 10.13B | 10.34B | 8.46B | 11.81B | 8.77B |
| Total Liabilities | 19.83B | 19.59B | 20.36B | 21.97B | 24.30B | 20.89B |
| Stockholders Equity | 21.19B | 21.80B | 21.67B | 20.90B | 22.91B | 22.06B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 695.00M | 2.77B | -1.67B | -413.00M | 1.41B |
| Operating Cash Flow | 0.00 | 1.20B | 3.43B | -1.44B | 2.71B | 3.17B |
| Investing Cash Flow | 0.00 | -908.00M | -709.00M | -237.00M | -3.30B | -1.67B |
| Financing Cash Flow | 0.00 | 633.00M | -2.12B | 2.33B | 2.22B | -676.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | ¥11.17B | 7.56 | ― | 4.36% | -23.46% | 14.53% | |
62 Neutral | ¥12.08B | 9.01 | ― | 3.44% | -15.33% | 18.06% | |
62 Neutral | ¥14.62B | 9.64 | ― | 3.75% | 0.19% | -41.33% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ¥7.62B | 5.09 | ― | 3.58% | 10.95% | 105.00% | |
56 Neutral | ¥82.55B | 29.33 | ― | 5.49% | -9.75% | -30.70% | |
52 Neutral | ¥11.64B | 8.93 | ― | 4.61% | 2.52% | 455.59% |